University Products addresses impact of TBD on cattle
by Katie Pfaff
Vaccine maker, University Products, LLC, has highlighted the losses in the cattle industry and methods of potential prevention. Tick-borne disease (TBD) has led to an estimated revenue loss of $19 billion per year, according to the company, which published a study on bovine anaplasmosis in Frontiers of Veterinary Medicine.
Because the disease is often not detected until symptoms of anemia are severe and treatments are varied, including transfusion, tetracycline and feed infused with medication. Treatments can be difficult to administer and costly; the best approach could be vaccination, according to University Products.
According to Union Veterinary Clinic veterinarian, Dr. Bat Brantley: "In every case of anaplasmosis I saw last year, death was the first sign owners saw. There are treatments available for anaplasmosis, but by the time cattle are recognized as having clinical signs, they may be so sick that treatment is too late to be effective."
The company has developed a vaccine for anaplasmosis; the vaccination was developed by Gene Luther, DVM, Ph.D. While the vaccination does not prevent disease, the severity of the disease is reduced, according to University Products. A two-dose regimen is administered in year 1 with a subsequent annual booster.
Comments
Related Articles
More news
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment